Continue with FacebookLooking to list your PhD opportunities? Log in here.
antibodies PhD Projects, Programmes & Scholarships
We have 35 antibodies PhD Projects, Programmes & Scholarships
PhD saved successfully
Last chance to apply
EASTBIO: Monoclonal antibodies targeting the fungal cell surface: next generation antifungal therapeutics
Supervisors. Professor Carol Munro -. University of Aberdeen, Institute of Medical Sciences - c.a.munro@abdn.ac.uk. Professor Daan Van Aalten. Read more
Precise, peptide-directed loading of drugs onto therapeutic antibodies for targeted imaging and treatment of tumors.
The PhD project aims to develop a non-covalent technology for loading small molecules and therapeutic enzymes onto monoclonal antibodies thus addressing issues in preparations of antibody-drug conjugates, such as poor yields and non-specific conjugation of the drugs resulting in compromised immunoaffinity. Read more
Therapeutic opportunities emerging from studies of immune checkpoints
Our focus has been on the cell biology of the T-cell surface. Read more
Therapeutic opportunities emerging from studies of immune checkpoints
Our focus has been on the cell biology of the T-cell surface. Read more
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens
Universal influenza vaccines are a major global R&D vaccine priority. The Temperton (ORCID. https://orcid.org/0000-0002-7978-3815). Read more
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens
Universal influenza vaccines are a major global R&D vaccine priority. The Temperton (ORCID. https://orcid.org/0000-0002-7978-3815). Read more
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
Overview. Human cytomegalovirus (HCMV) establishes lifelong infections of the host with >60% infected across the globe. In healthy children and adults HCMV produces mild symptoms like influenza or mononucleosis. Read more
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
Overview. Human cytomegalovirus (HCMV) establishes lifelong infections of the host with >60% infected across the globe. In healthy children and adults HCMV produces mild symptoms like influenza or mononucleosis. Read more
Developing molecularly imprinted polymeric nanocarriers for targeted cancer immunotherapy
This exciting interdisciplinary research will marry expertise in molecular imprinted polymers, nanomedicine and cancer immunotherapy. Read more
Evaluation of humoral response to NeuVac mRNA vaccine
1-year Master of Research Programme. Project Description. Neuroblastoma is one of the most aggressive childhood cancers contributing to 15% of cancer-related childhood deaths. Read more
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers
Overview. The need to quickly generate new diagnostic tools and therapies in the battle against viral diseases has been highlighted recently by the continuing global pandemic caused by the SARS-CoV-2 virus. Read more
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers
Overview. The need to quickly generate new diagnostic tools and therapies in the battle against viral diseases has been highlighted recently by the continuing global pandemic caused by the SARS-CoV-2 virus. Read more
Antibody Purification
We are developing a non-chromatographic, ligand-free general platform for antibody purification that is simple to implement, easy to upscale, cost-effective, and as such may provide a true alternative to the gold-standard technology. Read more
A new approach to CRISPR-Cas adaptation and the discovery of host accessory-proteins
Bacteria provide many health benefits and eco-environmental services. Although physically simple, they have a sophisticated immune system, CRISPR-Cas. Read more
Freeze-drying of Pharmaceutical Drug Products
A PhD scholarship is available (subject to contract) for this three-year project to be completed in collaboration with AstraZeneca, at De Montfort University, Leicester, beginning October 2022. Read more